Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2001

View Archived Issues

Sonus begins phase I evaluation of less toxic form of paclitaxel

Immune system improvement reported for Hollis-Eden's HIV therapy HE-2000

Peregrine reports promising interim results from Cotara brain cancer trial

The former Allelix Neuroscience issued patent for new GlyT-2 transporter inhibitors

Neurocrine's insomnia agent shows fewer next-day adverse effects than conventional drugs

Fujisawa to reorganize European operations

Seven-day transdermal analgesic to be developed by 3M and Purdue

Aurora Biosciences and Allergan establish ion channel discovery collaboration

Cell Genesys creates CNS gene therapy subsidiary

Cephalon and R.W. Johnson to collaborate on protein kinase inhibitors

Nonpeptide caspase inhibitor holds promise for patients with fulminant hepatic failure

Preclinical studies further define effects underlying tranilast's efficacy in preventing restenosis

DepoMorphine enters late-stage development at SkyePharma

Nutropin Depot development expanded by Genentech and Alkermes

AxyS advances development of APC-2059 for two different indications

Dyax and Abgenix seek novel antibody technology

Pivotal U.S. hepatitis C program begins for Zadaxin plus Pegasys

FDA approves study of KeraVision's Intacs inserts trial

Immune Network and InNexus establish collaboration regarding AIDS technologies

Impact of SERMs on stroke examined in rat model using LY-353381.HCl

Inhibitors of growth factor receptor tyrosine kinases developed at BMS

Abbott designs modulators of neurotransmitter release for therapeutic use

New compounds acting on cell proliferation, differentiation for keratinization disorders

Potent and selective factor Xa inhibitors patented by Cor Therapeutics

New antitumor prodrugs activated by FAPalpha

Neurogen scientists synthesize new series of brain GABA-A receptor ligands

Blockade of E-selectin provides neuroprotection in mouse stroke model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...